Characteristics and Outcome of SARS-CoV-2 Infection in Cancer PatientsClémence Basse, Paul Cottu, Anne-Sophie Bouyer et al.|JNCI Cancer Spectrum|2020Cited by 60
Characteristics and outcome of SARS-CoV-2 infection in cancer patients.Clémence Basse, Paul Cottu, Sarah Diakite et al.|medRxiv|2020Cited by 18
Efficacy and Safety of Erythropoietic-Stimulating Agents with Ruxolitinib in Myelofibrosis Patients : A Retrospective Analysis on 45 Patients. on Behalf of the French Intergroup of Myeloproliferative Disorders (FIM)Sandra Malak, Lydia Roy, Pascale Cony‐Makhoul et al.|Blood|2016Cited by 3
Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) RegistryBrigitte Dupriez, Jean‐Jacques Kiladjian, Sylvie Chevret et al.|Blood|2016Cited by 1